本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Tango Therapeutics Inc.

23.49
+0.14000.60%
盤後23.490.00000.00%19:30 EDT
成交量:172.19萬
成交額:4,121.35萬
市值:39.70億
市盈率:-27.96
高:24.63
開:23.79
低:23.41
收:23.35
52周最高:34.39
52周最低:6.69
股本:1.69億
流通股本:1.43億
量比:0.70
換手率:1.20%
股息:- -
股息率:- -
每股收益(TTM):-0.8400
每股收益(LYR):-0.8746
淨資產收益率:-21.34%
總資產收益率:-12.99%
市淨率:3.87
市盈率(LYR):-26.86

資料載入中...

2025/05/12

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025/05/12

重要事件披露

Form 8-K - Current report
2025/02/27

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2025/02/27

年度報告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2025/02/27

重要事件披露

Form 8-K - Current report
2025/01/13

重要事件披露

Form 8-K - Current report
2024/11/20

超過5%披露

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
2024/11/07

超過5%披露

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
2024/11/06

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/11/06

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/11/06

重要事件披露

Form 8-K - Current report
2024/10/28

超過5%披露

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
2024/10/25

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/10/22

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/10/22

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/10/15

超過5%披露

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
2024/10/15

超過5%披露

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
2024/09/13

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/09/05

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/09/04

超過5%披露

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]